J.P. Morgan Private Wealth Advisors LLC - SYNTA PHARMACEUTICALS CORP ownership

SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 93 filers reported holding SYNTA PHARMACEUTICALS CORP in Q3 2014. The put-call ratio across all filers is 1.91 and the average weighting 1.0%.

Quarter-by-quarter ownership
J.P. Morgan Private Wealth Advisors LLC ownership history of SYNTA PHARMACEUTICALS CORP
ValueSharesWeighting
Q2 2015$65,000
+124.1%
29,096
+94.0%
0.00%
Q1 2015$29,000
-27.5%
15,0000.0%0.00%
Q4 2014$40,000
-11.1%
15,0000.0%0.00%
-100.0%
Q3 2014$45,000
-26.2%
15,0000.0%0.00%0.0%
Q2 2014$61,000
-6.2%
15,0000.0%0.00%0.0%
Q1 2014$65,00015,0000.00%
Other shareholders
SYNTA PHARMACEUTICALS CORP shareholders Q3 2014
NameSharesValueWeighting ↓
CAXTON CORP 23,634,349$149,133,00099.87%
Perceptive Advisors 4,762,472$30,052,0001.24%
QVT Financial LP 1,750,285$11,044,0000.75%
NBW CAPITAL LLC 404,721$2,554,0000.45%
Tekla Capital Management LLC 489,750$3,090,0000.34%
MILES CAPITAL, INC. 57,904$365,0000.21%
FULLER & THALER ASSET MANAGEMENT, INC. 435,200$2,746,0000.16%
Old West Investment Management, LLC 49,136$310,0000.15%
Integre Asset Management, LLC 84,420$533,0000.14%
SABBY MANAGEMENT, LLC 250,952$1,584,0000.10%
View complete list of SYNTA PHARMACEUTICALS CORP shareholders